AlzeCure Pharma (ALZCUR) — Financial Flexibility Index
AlzeCure Pharma (ALZCUR) has a Financial Flexibility Index of -0.48x as of September 2025. Free cash flow of Skr-7.62 Million (operating CF Skr-7.62 Million minus capex Skr0.00) represents 0% of total liabilities (Skr15.93 Million). Also explore how fast is AlzeCure Pharma growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
AlzeCure Pharma Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for AlzeCure Pharma across 8 annual periods. Check ALZCUR PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for AlzeCure Pharma (2017–2024)
Year-by-year free cash flow to debt coverage for AlzeCure Pharma. For the full company profile including market capitalisation, see how much is AlzeCure Pharma worth.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.24x | Skr-35.00 Million | Skr-35.12 Million | Skr8.25 Million | ▼ -1241.7% |
| 2023 | 0.37x | Skr3.06 Million | Skr3.06 Million | Skr8.23 Million | ▲ +103.9% |
| 2022 | -9.65x | Skr-99.91 Million | Skr-99.91 Million | Skr10.35 Million | ▼ -73.2% |
| 2021 | -5.57x | Skr-70.58 Million | Skr-70.64 Million | Skr12.67 Million | ▲ +42.8% |
| 2020 | -9.73x | Skr-68.84 Million | Skr-69.51 Million | Skr7.07 Million | ▲ +5.3% |
| 2019 | -10.28x | Skr-48.82 Million | Skr-50.28 Million | Skr4.75 Million | ▼ -32.4% |
| 2018 | -7.76x | Skr-35.81 Million | Skr-36.27 Million | Skr4.61 Million | ▼ -294.8% |
| 2017 | -1.97x | Skr-8.15 Million | Skr-8.42 Million | Skr4.15 Million | — |